Crinetics Pharmaceuticals (CRNX) Competitors $31.77 -0.40 (-1.24%) Closing price 04:00 PM EasternExtended Trading$31.76 0.00 (-0.02%) As of 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRNX vs. MRNA, ASND, VTRS, QGEN, BPMC, ROIV, RVMD, BBIO, ELAN, and VRNAShould you be buying Crinetics Pharmaceuticals stock or one of its competitors? The main competitors of Crinetics Pharmaceuticals include Moderna (MRNA), Ascendis Pharma A/S (ASND), Viatris (VTRS), Qiagen (QGEN), Blueprint Medicines (BPMC), Roivant Sciences (ROIV), Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Elanco Animal Health (ELAN), and Verona Pharma (VRNA). These companies are all part of the "pharmaceutical products" industry. Crinetics Pharmaceuticals vs. Its Competitors Moderna Ascendis Pharma A/S Viatris Qiagen Blueprint Medicines Roivant Sciences Revolution Medicines BridgeBio Pharma Elanco Animal Health Verona Pharma Crinetics Pharmaceuticals (NASDAQ:CRNX) and Moderna (NASDAQ:MRNA) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends, community ranking and profitability. Do analysts rate CRNX or MRNA? Crinetics Pharmaceuticals presently has a consensus target price of $74.56, suggesting a potential upside of 134.67%. Moderna has a consensus target price of $46.61, suggesting a potential upside of 74.77%. Given Crinetics Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts clearly believe Crinetics Pharmaceuticals is more favorable than Moderna.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crinetics Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.91Moderna 4 Sell rating(s) 15 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.04 Is CRNX or MRNA more profitable? Crinetics Pharmaceuticals has a net margin of 0.00% compared to Moderna's net margin of -110.04%. Moderna's return on equity of -28.74% beat Crinetics Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Crinetics PharmaceuticalsN/A -36.12% -31.89% Moderna -110.04%-28.74%-21.83% Which has more volatility and risk, CRNX or MRNA? Crinetics Pharmaceuticals has a beta of 0.28, meaning that its share price is 72% less volatile than the S&P 500. Comparatively, Moderna has a beta of 1.86, meaning that its share price is 86% more volatile than the S&P 500. Which has higher valuation & earnings, CRNX or MRNA? Crinetics Pharmaceuticals has higher earnings, but lower revenue than Moderna. Crinetics Pharmaceuticals is trading at a lower price-to-earnings ratio than Moderna, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCrinetics Pharmaceuticals$760K3,913.94-$214.53M-$3.82-8.32Moderna$3.14B3.29-$3.56B-$8.73-3.05 Does the media favor CRNX or MRNA? In the previous week, Moderna had 14 more articles in the media than Crinetics Pharmaceuticals. MarketBeat recorded 22 mentions for Moderna and 8 mentions for Crinetics Pharmaceuticals. Crinetics Pharmaceuticals' average media sentiment score of 1.13 beat Moderna's score of 0.51 indicating that Crinetics Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crinetics Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Moderna 11 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in CRNX or MRNA? Moderna received 57 more outperform votes than Crinetics Pharmaceuticals when rated by MarketBeat users. However, 69.43% of users gave Crinetics Pharmaceuticals an outperform vote while only 53.07% of users gave Moderna an outperform vote. CompanyUnderperformOutperformCrinetics PharmaceuticalsOutperform Votes15969.43% Underperform Votes7030.57% ModernaOutperform Votes21653.07% Underperform Votes19146.93% Do institutionals and insiders believe in CRNX or MRNA? 98.5% of Crinetics Pharmaceuticals shares are held by institutional investors. Comparatively, 75.3% of Moderna shares are held by institutional investors. 4.6% of Crinetics Pharmaceuticals shares are held by company insiders. Comparatively, 11.0% of Moderna shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryCrinetics Pharmaceuticals beats Moderna on 10 of the 19 factors compared between the two stocks. Get Crinetics Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRNX vs. The Competition Export to ExcelMetricCrinetics PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.97B$6.85B$5.56B$8.50BDividend YieldN/A2.53%5.28%4.16%P/E Ratio-8.528.4326.6419.64Price / Sales3,913.94262.52407.99152.17Price / CashN/A65.8538.2534.64Price / Book3.946.536.974.60Net Income-$214.53M$143.25M$3.23B$248.06M7 Day Performance-3.76%0.21%-0.98%-1.03%1 Month Performance2.65%10.92%7.70%3.50%1 Year Performance-32.25%2.44%31.32%12.68% Crinetics Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRNXCrinetics Pharmaceuticals3.5338 of 5 stars$31.77-1.2%$74.56+134.7%-32.7%$2.97B$760K-8.52210Positive NewsAnalyst RevisionMRNAModerna4.4446 of 5 stars$28.14+2.5%$53.58+90.4%-81.5%$10.88B$3.14B-3.033,900Trending NewsGap DownASNDAscendis Pharma A/S3.389 of 5 stars$173.15+0.1%$217.73+25.7%+30.2%$10.56B$368.70M-24.39640Analyst ForecastAnalyst RevisionVTRSViatris2.5133 of 5 stars$8.81+1.1%$10.40+18.0%-14.5%$10.34B$14.33B-11.9137,000QGENQiagen3.336 of 5 stars$46.17+1.5%$48.42+4.9%+10.2%$10.26B$2.00B128.566,030BPMCBlueprint Medicines1.1558 of 5 stars$127.97+0.1%$129.35+1.1%+20.8%$8.26B$562.12M-118.49640High Trading VolumeROIVRoivant Sciences2.3485 of 5 stars$11.08-1.3%$17.50+57.9%+5.9%$7.91B$29.05M-73.86860RVMDRevolution Medicines4.4239 of 5 stars$40.58-1.2%$67.08+65.3%+2.8%$7.56B$742K-11.30250Positive NewsBBIOBridgeBio Pharma4.5481 of 5 stars$39.03+1.1%$57.36+47.0%+38.2%$7.41B$127.42M-13.69400Insider TradeAnalyst RevisionELANElanco Animal Health1.0374 of 5 stars$13.94+0.3%$15.17+8.8%-20.6%$6.92B$4.43B34.859,800Gap DownVRNAVerona Pharma2.1246 of 5 stars$84.64+0.4%$82.13-3.0%+527.1%$6.86B$118.54M-44.0830Trending NewsAnalyst ForecastInsider TradeAnalyst Revision Related Companies and Tools Related Companies Moderna Competitors Ascendis Pharma A/S Competitors Viatris Competitors Qiagen Competitors Blueprint Medicines Competitors Roivant Sciences Competitors Revolution Medicines Competitors BridgeBio Pharma Competitors Elanco Animal Health Competitors Verona Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRNX) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRNX Stock Free CRNX Stock Alerts